Industry News
Biomarker laboratory to mine the proteome
A new Biomarker Discovery Laboratory was opened today at Australian Proteomics Analysis Facility (APAF) at Macquarie University, approximately ten years after scientists including Keith Williams and Marc Wilkins initiated the science now known as 'proteomics' on that very site. [ + ]
Scientists search for Parkinsons genes in Tasmania
Within a day of putting out a call for families with a history of Parkinson's disease to participate in a project to identify susceptibility genes for the disease, Hobart's Menzies Research Institute had five families signed up. [ + ]
Leibman jumps ship to Heartware
Howard Leibman, who advised Heartware (ASX:HTW) during its recent ASX-listing as an associate director of specialist biotech investment bank Emerging Growth Capital, has been poached by the artificial heart company. [ + ]
CSIRO applies for GM rice field trial
CSIRO Plant Industry has applied to the Office of the Gene Technology Regulator (OGTR) to conduct a field trial of gene-knockout rice varieties, as part of the national research organisation's contribution to the international 'Green Machine' functional genomics project. [ + ]
In brief: Acrux, Meditech, Psivida
Melbourne's Acrux (ASX: ACR) has Adam Watkinson as its chief scientific officer. Watkinson is currently manager of drug delivery research and project manager at UK pharmaceutical company ProStrakan . [ + ]
Axon, C3 alumni among Clunies Ross winners
Bioscience entrepreneurs, including Axon Instruments founder Alan Finkel and Fiona Wood and Marie Stoner of Clinical Cell Culture, have dominated the winners' circle at this year's ATSE Clunies Ross Awards. [ + ]
Metabolic releases data on neuropathic pain drug
A preclinical trial of Metabolic Pharmaceuticals' (ASX:MBP) conotoxin peptide painkiller hints that if it makes it to the clinic, it could provide a health bonus for patients suffering chronic neuropathic pain. [ + ]
Phylogica gets IP boost
The US Patent Office has granted Perth biotech Phylogica's application for a patent on its technology for isolating biological modulators from its burgeoning library of gene fragments from "extremophile" microbes. [ + ]
APAF to launch biomarker laboratory
The Australian Proteome Analysis Facility (APAF) is gearing up to launch its new Biomarker Discovery Laboratory and is already on the verge of signing a pharmaceutical company partner for a project. [ + ]
Bacterial genomes found lurking
When scientists finished sequencing the genomes of seven species of fruit fly last year, little did they know that they had also sequenced the genes of several bacteria that dwell undetected inside fruit fly embryos.
[ + ]In brief: Biota, Cytopia, Pharmaxis, Ventracor, Vision Systems, Replikun
Andrew Macdonald has resigned as chief financial officer at Melbourne-based Biota Holdings (ASX:BTA) and is taking up the CFO position at fellow biotech Cytopia (ASX:CYT). Cytopia is relocating its corporate HQ from Brisbane to Melbourne. Macdonald has given three months' notice at Biota. [ + ]
New Proteome boss talks of company in transition
New Proteome Systems chief executive Stephen Porges (ASX:PXL) believes the company is caught in the middle of a typical biotech transformation from its original focus as a tools business to a diagnostics and therapeutics business -- which is where its real future lies. [ + ]
US ponders loosening NIH ethics rules
Strict new ethics rules imposed on National Institutes of Health staff to prevent lucrative deals with drug companies may be loosened if warranted, Health and Human Services Secretary Mike Leavitt has said. [ + ]
SkyePharma jumps as lung drug deal nears
Britain's SkyePharma is close to a deal on one of its lung drugs that could be worth US$160 million, the drug delivery firm has claimed, boosting its shares as it posted a narrower loss for 2004. [ + ]
Sydney scientist develops new hearing software
A University of Sydney scientist has developed a software algorithm which improves the ability of the hearing-impaired to hear in noisy environments. [ + ]